CTLA4 and urinary bladder carcinoma: administered a combination of inosine + CpG + anti‐CTLA‐4 in mouse models of colorectal, melanoma, and bladder cancer, all of which showed that inosine enhanced the antitumor immunity of anti‐CTLA‐4 in the presence of the co‐stimulatory factor CPG.26, 43